Guest Blog by: Agata do Espirito Santo Soares, CAMO-Net Timor-Leste
In December 2024, infectious disease experts from around the world gathered in South Africa for the International Congress on Infectious Diseases (ISID) and the CAMO-Net Meeting. These events brought together over 2,500 participants to address one of the most pressing global health challenges: antimicrobial resistance (AMR).
Why These Meetings Matter
AMR is a growing threat, fueled by factors such as climate change, poverty, and limited access to medicines. The ISID Congress provided a platform for sharing cutting-edge research and strategies to optimize antimicrobial use. For members of the Centres for Antimicrobial Optimisation Network (CAMO-Net), it was an opportunity to strengthen collaborations and exchange best practices.
Key Takeaways from ISID
Pharmacists’ Role in AMS:
Evidence from South Africa showed that pharmacist-led antimicrobial stewardship (AMS) interventions improved treatment timelines across 33 hospitals. Global AMR Landscape: Presentations highlighted alarming resistance trends, such as MRSA rates of 65% and widespread carbapenem resistance in some regions. Discussions revealed systemic issues like low investment in health budgets and limited use of logistics management systems in low-resource settings.
CAMO-Net Collaboration
The CAMO-Net meeting emphasized the importance of in-person engagement for building trust and fostering innovation. Members from Timor-Leste and Brazil shared strategies for strengthening public health delivery, underscoring the value of global partnerships in tackling AMR.
Impact and Outcomes
- Enhanced professional development and understanding of AMS and AMR strategies.
- Provided networking opportunities with global infectious disease experts.
- Offered insights into evidence-based interventions and advanced pharmacokinetic optimization techniques.
- Highlighted actionable steps for countries like Timor-Leste, including improving surveillance systems and community engagement.
Final Thoughts:
AMR is not just a scientific challenge—it’s a social, economic, and political issue. Global collaboration, knowledge sharing, and commitment at all levels are essential to safeguard the effectiveness of antimicrobials for future generations.
